MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma
Authors
Keywords
miR-10a-5p, TFAP2C, PDAC, Chemoresistance, Prognosis
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 37, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-04-04
DOI
10.1186/s13046-018-0739-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TFAP2C promotes lung tumorigenesis and aggressiveness through miR-183- and miR-33a-mediated cell cycle regulation
- (2016) J Kang et al. ONCOGENE
- Long non-coding RNA TUSC7 acts a molecular sponge for miR-10a and suppresses EMT in hepatocellular carcinoma
- (2016) Yufeng Wang et al. TUMOR BIOLOGY
- MicroRNA-10a is reduced in breast cancer and regulated in part through retinoic acid
- (2015) Sonja Khan et al. BMC CANCER
- TFAP2C expression in breast cancer: correlation with overall survival beyond 10 years of initial diagnosis
- (2015) Susan M. Perkins et al. BREAST CANCER RESEARCH AND TREATMENT
- MicroRNA-10a silencing reverses cisplatin resistance in the A549/cisplatin human lung cancer cell line via the transforming growth factor-β/Smad2/STAT3/STAT5 pathway
- (2015) WEI SUN et al. Molecular Medicine Reports
- The prognostic significance of RUNX2 and miR-10a/10b and their inter-relationship in breast cancer
- (2014) Chih-Hao Chang et al. Journal of Translational Medicine
- TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis
- (2014) A R Cyr et al. ONCOGENE
- MicroRNA-10a Is Down-Regulated by DNA Methylation and Functions as a Tumor Suppressor in Gastric Cancer Cells
- (2014) Hongyan Jia et al. PLoS One
- Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptor-positive breast cancer following tamoxifen treatment
- (2013) Reiner Hoppe et al. EUROPEAN JOURNAL OF CANCER
- Overexpression of miR-10a and miR-375 and downregulation of YAP1 in medullary thyroid carcinoma
- (2013) Jena Hudson et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNA-10a is Overexpressed in Human Pancreatic Cancer and Involved in Its Invasiveness Partially via Suppression of the HOXA1 Gene
- (2012) Kenoki Ohuchida et al. ANNALS OF SURGICAL ONCOLOGY
- Expression of the RET Proto-oncogene Is Regulated by TFAP2C in Breast Cancer Independent of the Estrogen Receptor
- (2012) Philip M. Spanheimer et al. ANNALS OF SURGICAL ONCOLOGY
- MicroRNA-10a targets CHL1 and promotes cell growth, migration and invasion in human cervical cancer cells
- (2012) Mei-Jing Long et al. CANCER LETTERS
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- miRNA expression profile in primary gastric cancers and paired lymph node metastases indicates that miR-10a plays a role in metastasis from primary gastric cancer to lymph nodes
- (2011) WEIDONG CHEN et al. Experimental and Therapeutic Medicine
- Down-regulation of microRNA 10a expression in esophageal squamous cell carcinoma cells
- (2010) NAOKI INOUE et al. Oncology Letters
- Survival prediction of gastric cancer by a seven-microRNA signature
- (2009) X. Li et al. GUT
- Overexpression ofTFAP2Cin invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival
- (2008) JMW Gee et al. JOURNAL OF PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More